Study #2020-1052
Randomized controlled trial of accessible online genetic services for cascade testing of BRCA mutation carriers versus usual care in a clinic setting
MD Anderson Study Status
Enrolling
Treatment Agent
Description
The purpose of this study is to assess an intervention that incorporates engagement strategies with a medical team navigator, an educational video and accessible genetic testing services to maximize the genetic testing and education of at-risk relatives. In this study, first degree relatives who agree to participate will either receive this intervention or standard of care. The investigators do not know if the facilitated interventional method will be more effective than the standard of care method. This research is being done because identification of patients with inherited gynecologic/breast cancer syndromes is critical to enable delivery of tailored cancer treatment and cancer prevention to both the patients and their at-risk relatives. Cascade genetic testing, defined as extending genetic testing to the family members of affected patients, results in a more precise risk assessment and initiation of appropriate cancer screening and prevention strategies. Therefore, this trial will compare the efficacy of a multicomponent facilitated intervention for first degree relatives vs. standard of care in terms of the overall proportion of first degree relatives who complete genetic testing by 6 months (primary outcome).
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
BRCA1 Mutation;BRCA2 Mutation
Study phase:
Not applicable
Physician name:
Jose Rauh-Hain
Department:
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
1-855-479-2433
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.